SecurityCDNA / CareDx, Inc. (14167L103)
IndustryMedical Laboratories
Common Shares Outstanding36,346,124 shares (as of 2018-06-30)
Total Insiders22
Total Directors8
Total Officers12

Stock Insider Trading (from SEC Form 4)

CareDx, Inc. insider trades are listed in the following table, followed by a table containing the full transaction history. Insiders are officers, directors, or significant investors in a company. In general, it is generally illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.

CDNA / CareDx, Inc. insiders include King Sasha, Cohen Fred E, BYERS BROOK H, Sninsky John Joseph, Nelles Mitchell J, MILLER DOUGLAS S, Maag Peter, DeFonzo Joshua, Midroc Invest AB, and SNYDERMAN RALPH, Bickerstaff George, Yee James P, LUDLUM KEN, Goldberg Michael, Meyer Matthew J., HAGSTROM WILLIAM A, Karlsson Anders, Whitson Todd, Bell Michael Brian, GAGNON NEIL, Abernethy Amy Constanti Charles, .

Insider Roster

Insider Dir Off 10% Shares Owned
Bell Michael Brian Chief Financial Officer
X 68,593
King Sasha Chief Commercial Officer
X 65,042
Bickerstaff George Director
X 51,007
HAGSTROM WILLIAM A Director
X 39,532
Goldberg Michael Director
X 131,123
SNYDERMAN RALPH Director
X 69,996
Cohen Fred E Director
X 37,901
Nelles Mitchell J Chief Operating Officer
X 86,889
Yee James P Chief Medical Officer
X 63,102
Maag Peter See Remarks, Director
X X 474,037
Abernethy Amy Director
X 10,000
GAGNON NEIL 10% Owner
X 2,207,064
Sninsky John Joseph Chief Scientific Officer
X 22,309
Karlsson Anders Chief Commercial Officer
X 9,638
Midroc Invest AB 10% Owner
X 3,934,872
MILLER DOUGLAS S Director
X 17,695
Constanti Charles Chief Financial Officer
X
Whitson Todd Chief Commercial Officer
X
BYERS BROOK H
Meyer Matthew J. Chief Business Officer
X
DeFonzo Joshua Chief Commercial Officer
X
LUDLUM KEN Chief Financial Officer
X

Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b-5 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Form Insider Code 10b-5 Direct Share
Price
Shares
Changed
Remaining
Shares
Post Value
2018-08-14 4 Bell Michael Brian S D 16.837 -12,500 68,593 1,154,900
2018-08-01 4 King Sasha S D 14.0341 -9,458 65,042 912,806
2018-08-01 4 King Sasha M D 1.07 2,708 74,500
2018-08-01 4 King Sasha M D 1.00 3,750 71,792
2018-07-01 4 Abernethy Amy A D 10,000 10,000
2018-06-29 4 Maag Peter A D 50,000 474,037
2018-06-29 4 Maag Peter A D 150,000 424,037
2018-06-29 4 Bell Michael Brian A D 25,000 89,738
2018-06-29 4 Bell Michael Brian A D 50,000 64,738
2018-06-29 4 King Sasha A D 10,000 71,500
2018-06-29 4 King Sasha A D 50,000 61,500
2018-06-29 4 Yee James P A D 10,000 63,102
2018-06-29 4 Yee James P A D 10,000 53,102
2018-07-02 4 Nelles Mitchell J S D 12.4823 -39,649 86,889 1,084,575
2018-07-02 4 Nelles Mitchell J M D 2.30 9,000 126,538
2018-07-02 4 Nelles Mitchell J M D 5.27 19,250 117,538
2018-07-02 4 Nelles Mitchell J M D 3.70 3,649 98,288
2018-06-29 4 Nelles Mitchell J A D 5,000 94,639
2018-06-29 4 Nelles Mitchell J A D 10,000 89,639
2018-06-20 4 SNYDERMAN RALPH A D 5,000 68,799
2018-06-20 4 Cohen Fred E A D 5,000 37,901
2018-06-29 4 Goldberg Michael A D 1,756 132,879
2018-06-29 4 HAGSTROM WILLIAM A A D 740 40,272
2018-06-29 4 Bickerstaff George A D 1,197 52,204
2018-06-29 4 SNYDERMAN RALPH A D 1,197 69,996
2018-06-20 4 Goldberg Michael A D 5,000 131,123
2018-06-20 4 HAGSTROM WILLIAM A A D 5,000 39,532
2018-06-20 4 Bickerstaff George A D 5,000 51,007
2018-05-24 4 GAGNON NEIL G D -50,000 2,207,064
2018-04-26 4 GAGNON NEIL By Managing Member as General Partner of Gagnon Investment Associates P I 9.42 10,136 2,257,064 21,261,543
2018-04-02 4 Goldberg Michael A D 3,258 126,123
2018-04-02 4 Bickerstaff George A D 2,221 46,007
2018-04-02 4 SNYDERMAN RALPH A D 2,221 63,799
2018-04-02 4 HAGSTROM WILLIAM A A D 1,373 34,532
2018-03-27 4 Maag Peter S X D 7.869 -15,000 274,037 2,156,397
2018-03-20 4 Maag Peter M D 0.548 50,000 289,037
2018-02-14 4 Maag Peter M D 0.548 -89,938 239,037
2018-01-29 4 Maag Peter F D 6.25 -1,450 149,099
2018-01-29 4 Sninsky John Joseph F D 6.25 -805 22,309
2018-01-29 4 Nelles Mitchell J F D 6.25 -805 79,639
2018-01-29 4 Yee James P F D 6.25 -805 43,102
2018-01-19 4 Maag Peter A D 44,425 154,275
2018-01-19 4 Nelles Mitchell J A D 8,858 82,135
2018-01-19 4 Bell Michael Brian A D 14,013 14,738
2018-01-19 4 Karlsson Anders A D 9,638 9,638
2018-01-22 4 Maag Peter F D 6.29 -3,726 106,124
2018-01-22 4 Sninsky John Joseph F D 6.29 -886 23,114
2018-01-22 4 Nelles Mitchell J F D 6.29 -1,691 71,586
2018-01-22 4 Yee James P F D 6.29 -1,691 43,907
2018-01-02 4 Bickerstaff George A D 2,004 43,786
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...

Related News Stories

Teladoc (TDOC) Hits 52-Week High, Will the Rally Continue?

2018-08-13 zacks
Teladoc Health, Inc. (TDOC - Free Report) stock gained traction from a strong second-quarter 2018 earnings release as well as a solid guidance. The stock hit a 52 week-high of $71.9 on Aug 10. (5-0)

CareDx, Inc. (CDNA) CEO Peter Maag on Q2 2018 Results - Earnings Call Transcript

2018-08-12 seekingalpha
Greetings, and welcome to the CareDx Second Quarter 2018 Earnings Conference Call. At this time all participants are in a listen only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. (4-0)

CareDx (CDNA) Reports Q2 Loss, Tops Revenue Estimates

2018-08-09 zacks
CareDx (CDNA - Free Report) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.17 per share a year ago. These figures are adjusted for non-recurring items. (4-0)

CareDx's (CDNA) CEO Peter Maag on Q1 2018 Results - Earnings Call Transcript

2018-05-13 seekingalpha
Greetings, and welcome to the CareDx First Quarter 2018 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. (2-0)

CareDx's (CDNA) CEO Peter Maag on Q4 2017 Results - Earnings Call Transcript

2018-03-23 seekingalpha
Greetings, and welcome to the CareDx Fourth Quarter 2017 Earnings Conference Call. [Operator instructions] As a reminder, this conference is being recorded. (5-0)